82 related articles for article (PubMed ID: 26514504)
1. IL-17A Levels in the Sera of Patients with Gastric Cancer Show Limited Elevation.
Malek-Hosseini Z; Taherinejad M; Malekzadeh M; Ghaderi A; Doroudchi M
Asian Pac J Cancer Prev; 2015; 16(16):7149-53. PubMed ID: 26514504
[TBL] [Abstract][Full Text] [Related]
2. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma.
Malekzadeh M; Dehaghani AS; Ghaderi A; Doroudchi M
Cancer Biomark; 2013 Jan; 13(6):417-25. PubMed ID: 24595078
[TBL] [Abstract][Full Text] [Related]
3. IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.
Zhong F; Cui D; Tao H; Du H; Xing C
Oncol Rep; 2015 Nov; 34(5):2365-74. PubMed ID: 26352729
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
5. Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status.
Doroudchi M; Saidi M; Malekzadeh M; Golmoghaddam H; Khezri A; Ghaderi A
Future Oncol; 2013 Feb; 9(2):295-304. PubMed ID: 23414478
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma.
Doroudchi M; Pishe ZG; Malekzadeh M; Golmoghaddam H; Taghipour M; Ghaderi A
Asian Pac J Cancer Prev; 2013; 14(9):5225-30. PubMed ID: 24175805
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.
Tseng JY; Yang CY; Liang SC; Liu RS; Yang SH; Lin JK; Chen YM; Wu YC; Jiang JK; Lin CH
Clin Cancer Res; 2014 Jun; 20(11):2885-97. PubMed ID: 24677375
[TBL] [Abstract][Full Text] [Related]
8. Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas.
Karstens KF; Kempski J; Giannou AD; Freiwald E; Reeh M; Tachezy M; Izbicki JR; Lohse AW; Gagliani N; Huber S; Pelczar P
PLoS One; 2020; 15(4):e0231833. PubMed ID: 32298379
[TBL] [Abstract][Full Text] [Related]
9. Increased IL-17A in atrial fibrillation correlates with neutrophil to lymphocyte ratio.
Nikoo MH; Taghavian SR; Golmoghaddam H; Arandi N; Abdi Ardakani A; Doroudchi M
Iran J Immunol; 2014 Dec; 11(4):246-58. PubMed ID: 25549592
[TBL] [Abstract][Full Text] [Related]
10. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
Morsy H; Maher R; Negm D
J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of interleukin-17A and interleukin-23 are increased in patients with gonococcal infection.
Gagliardi MC; Starnino S; Teloni R; Mariotti S; Dal Conte I; Di Carlo A; Stefanelli P
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):129-32. PubMed ID: 21214637
[TBL] [Abstract][Full Text] [Related]
13. A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.
Lereclus E; Tout M; Girault A; Baroukh N; Caulet M; Borg C; Bouché O; Ternant D; Paintaud G; Lecomte T; Raoul W
BMC Cancer; 2017 Mar; 17(1):220. PubMed ID: 28347290
[TBL] [Abstract][Full Text] [Related]
14. Expression and location of IL-17A, E, F and their receptors in colorectal adenocarcinoma: Comparison with benign intestinal disease.
Liu Y; Sun X; Zhao X; An L; Wang Z; Jiang J; Shen W; Yang X; Sun Y
Pathol Res Pract; 2018 Apr; 214(4):482-491. PubMed ID: 29548809
[TBL] [Abstract][Full Text] [Related]
15. High plasma sST2 levels in gastric cancer and their association with metastatic disease.
Bergis D; Kassis V; Radeke HH
Cancer Biomark; 2016; 16(1):117-25. PubMed ID: 26835712
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M; Usul Afsar C; Serimez M; Karabulut S
J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
[TBL] [Abstract][Full Text] [Related]
17. Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms.
Adamsson J; Ottsjö LS; Lundin SB; Svennerholm AM; Raghavan S
Cytokine; 2017 Nov; 99():30-34. PubMed ID: 28683359
[TBL] [Abstract][Full Text] [Related]
18. Interleukins 17 and 23 in patients with gastric neoplasms.
Błogowski W; Madej-Michniewicz A; Marczuk N; Dołęgowska B; Starzyńska T
Sci Rep; 2016 Nov; 6():37451. PubMed ID: 27869179
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer.
Wu X; Zeng Z; Chen B; Yu J; Xue L; Hao Y; Chen M; Sung JJ; Hu P
Int J Cancer; 2010 Jul; 127(1):86-92. PubMed ID: 19904747
[TBL] [Abstract][Full Text] [Related]
20. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
